Drug resistant Plasmodium vivax malaria

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 6, 1997, Pages 749-752

  Whitby, Michael ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; AMODAQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; HALOFANTRINE; MELFOQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; TAFENOQUINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL OBSERVATION; CLINICAL PROTOCOL; DEVELOPING COUNTRY; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE TIME EFFECT RELATION; DRUG SENSITIVITY; DRUG TOLERANCE; HEART MUSCLE CONDUCTION DISTURBANCE; HEMOLYSIS; HUMAN; LABORATORY TEST; LIFE CYCLE; MALARIA; METHEMOGLOBINEMIA; PARASITEMIA; PATIENT MONITORING; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROPHYLAXIS; RECURRENT DISEASE; SCHIZONT; SUPERINFECTION; TREATMENT FAILURE; TREATMENT OUTCOME; TROPHOZOITE; TROPICAL MEDICINE; VENOUS BLOOD; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIMALARIALS; ASIA; CHLOROQUINE; DRUG RESISTANCE; HUMANS; MALARIA, VIVAX; PACIFIC ISLANDS; PLASMODIUM VIVAX; PRIMAQUINE;

EID: 0031450844     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.6.749     Document Type: Article

References (34)

1. World Health Organization. (1967). Chemotherapy of malaria: report of a WHO scientific group. WHO Technical Report Series 375, 42.
2. World Health Organization. (1973). Chemotherapy of malaria and resistance to anti-malarials: report of a WHO scientific working group. WHO Technical Report Series 529, 30.
3. Rieckmann, K. H., McNamara, J. V., Frishcher, H., Stockert, T. A., Carson, P. E. & Powell, R. D. (1968). Effects of chloroquine, quinine and cycloguanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene 17, 661-71.
4. Rieckmann, K. H., Sax, L. J., Campbell, G. H. & Mrema, J. E. (1978). Drug sensitivity of Plasmodium falciparum. An in-vitro microtechnique. Lancet i, 22-3.
5. Peters, W. (1987). Chemotherapy and Drug Resistance in Malaria, p. 379. Academic Press, London.
6. Bergqvist, Y. & Domeig-Nyberg, B. (1983). Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. Journal of Chromatography 272, 137-48.
7. Rieckmann, K. H., Yeo, A. E., Davis, D. R., Hutton, D. C., Wheatley, P. F. & Simpson, R. (1993). Recent military experience with malaria chemoprophylaxis. Medical Journal of Australia 158, 446-9.
8. Whitby, M., Wood, G., Veenedaal, J. R. & Rieckmann, K. (1989). Chloroquine resistant Plasmodium vivax. Lancet ii, 1395.
9. Schwartz, I. K., Lackritz, E. M. & Patchen, L. C. (1991). Chloroquine resistant Plasmodium vivax from Indonesia. New England Journal of Medicine 324, 927.
10. Baird, J. K., Basri, H., Purnomo, Bangs, M. J., Subianto, B., Patchen, L. C., et al. (1991). Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. American Journal of Tropical Medicine and Hygiene 44, 547-52.
11. Collignon, P. (1991). Chloroquine resistance in Plasmodium vivax. Journal of Infectious Diseases 164, 222-3.
12. Schuurkamp, G. J., Spicer, P. E., Kereu, R. K., Bulungol, P. K. & Rieckmann, K. H. (1992). Chloroquine resistant Plasmodium vivax in Papua New Guinea. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 121-2.
13. Murphy, G. S., Basri, H., Purnomo, Andersen, E. M., Bangs, M. J., Mount, D. L., et al. (1993). Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341, 96-100.
14. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyan-Hla-Aye & Nwe-Nwe-Yin. (1993). Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 687.
15. Thaithong, S., Siripoon, N., Seugorn, N., Bunnag, D. & Belae, G. H. (1989). Electrophoretic variance of enzymes in isolates of Plasmodium falciparum, P. malariae and P. vivax from Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 602-5.
16. Ahlm, C., Wistrom, J. & Carlsson, H. (1996). Chloroquine resistant Plasmodium vivax malaria in Borneo. Journal of Travel Medicine 3, 124.
17. Joshi, H., Subbaro, S. K., Raghavendra, K. & Scharma, V. P. (1989). Plasmodium vivax: enzyme polymorphism in isolates of Indian origin. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 179-81.
18. Garg, M., Gopinathan, N., Bodhe, P. & Kshirsagar, N. A. (1995). Vivax malaria resistant to chloroquine: case reports from Bombay. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 656-7.
19. Garavelli, P. L. & Corti, E. (1992). Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 128.
20. Cooper, W. C., Myatt, A. V., Hernundez, T., Jeffrey, G. M. & Coamey, G. R. (1953). Studies on human malaria. XXX. Comparison of primaquine, isopentaquine, SN-3883 and pamaquine as curative gents against sporazoite-induced Chesson strain vivax malaria. American Journal of Tropical Medicine and Hygiene 2, 949-57.
21. Black, R. H. (1981). Malaria in refugees from Indo-China as seen in Australia in 1980. Medical Journal of Australia 2, 324-5.
22. Fisher, G. U., Gordon, M. P., Lobel, H. O. & Runcik, K. (1970). Malaria in soldiers returning from Vietnam. Epidemiologic, therapeutic, and clinical studies. American Journal of Tropical Medicine and Hygiene 19, 27-39.
23. Pukrittayakamee, S., Vanijanonta, S., Chantra, A., Clemens, R. & White, N. J. (1994). Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. Journal of Infectious Diseases 169, 932-5.
24. Garnham, T. C. C. (1984). Lifecycle. In Antimalarial Drugs Vol. 1 (Peters, W. & Richards, W. H. G., Eds), p. 14. Springer-Verlag, New York.
25. Arnold, J., Alving, A. S. & Clayman, C. B. (1961). Induced primaquine resistance in vivax malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 55, 345-50.
26. Robson, J. M., Conroy, D., Cremin, J. M., Hannaford, R. & Dunn, T. A. (1993). Chloroquine resistant Plasmodium vivax: how common? Medical Journal of Australia 158, 502.
27. Marlar-Than, Myat-Phone-Kyaw, Aye-Tu-Soe, Khaing-Khaing-Gyi, Ma-Sabai & Myint-Oo (1995). Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 307-8.
28. Baird, J. K., Basri, H., Subianto, B., Fryauff, D. J., McElroy, P. D., Leksana, B. et al. (1995). Treatment of chloroquine resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. Journal of Infectious Diseases 171, 1678-82.
29. Loyola, E. G. & Rodriguez, M. H. (1992). Chloroquine resistant Plasmodium vivax in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 570.
30. Schmidt, L. H. (1978). Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). II Responses to chloroquine, quinine and pyrimethamine. American Journal of Tropical Medicine and Hygiene 27, 703-17.
31. Nosten, F. & Price, R. N. (1995). New antimalarials: a risk-benefit analysis. Drug Safety 12, 264-73.
32. Cooper, R. D. & Rieckmann, K. H. (1990). Efficacy of amodiaquine against a chloroquine-resistant strain of Plasmodium vivax. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 473.
33. Cooper, R. D., Milhous, W. K. & Rieckmann, K. H. (1994). The efficacy of WR238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 691-2.
34. White, N. (1996). Can amodiaquine be resurrected? Lancet 348, 1184-5.